Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-02 Sapir Alex See Remarks Grant or award · Stock option - Right to Buy +650,000 650,000
2025-01-24 Sapir Alex See Remarks Grant or award · Stock option - Right to Buy +582,000 582,000
2024-07-03 Sapir Alex See Remarks Option exercise +150,000 $3.27 $491K 193,360
2024-07-03 Sapir Alex See Remarks Option exercise · Stock option - Right to Buy −150,000 2,280,400
2024-03-04 Sapir Alex See Remarks Purchase +43,360 $11.35 $492K 43,360

Page 1 of 1 · 5 trades